Medicines in Development for Antimicrobial Resistance (AMR) 2021 Report

  03 May 2021

As the world confronts the COVID-19 public health crisis, now more than ever is the time to consider preparedness for a growing public health threat: antimicrobial resistance (AMR). AMR is a natural process that occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that make the medicines used to treat the infections they cause ineffective. Therefore, the more we use such medicines, the more resistance we may create. This means a robust and sustained pipeline of new and novel antimicrobial medicines is critical to ensure that new innovations and interventions can keep pace with these evolving pathogens.

Further reading: PhRMA
Author(s): PhRMA
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed